Home/Filings/4/0001628280-21-021008
4//SEC Filing

Bartram Richard 4

Accession 0001628280-21-021008

CIK 0001434868other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 4:48 PM ET

Size

6.3 KB

Accession

0001628280-21-021008

Insider Transaction Report

Form 4
Period: 2021-10-29
Bartram Richard
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-10-29+18,70043,852 total
Holdings
  • Stock Option (right to buy)

    Exercise: $8.94Exp: 2031-10-29Common Stock (26,500 underlying)
    26,500
Footnotes (2)
  • [F1]The awards will vest as follows: 50% shall vest upon CVOT public presentation of results; and 50% shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.
  • [F2]Consists of 43,852 shares of common stock held, including 1,535 shares acquired in Esperion's Employee Stock Purchase Plan.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001723729

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:48 PM ET
Size
6.3 KB